RNA

Avidity Biosciences Inc.

Price

$13.71

return (12m)

-68.86%

p/e

-2.32

p/bv

1.01

DIVIDEND YIELD

0.00%

RNA price

Avidity Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.84%

3 months

5.14%

1 year

-68.86%

2 years

-69.80%

5 years

-31.96%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals RNA

Valuation

P/E

-2.32

Sector -4.38

Industry -4.38

P/BV

1.01

Sector 2.02

Industry 2.02

P/Revenue (PSR)

6.02

Sector -4.40

Industry -4.40

EV/EBITDA

2.15

Sector -263.09

Industry -263.09

EV/EBIT

2.12

Sector -702.90

Industry -702.90

P/EBITDA

-2.26

Sector -4.39

Industry -4.39

P/EBIT

-2.24

Sector -4.73

Industry -4.73

P/Total Assets

0.77

Sector 1.49

Industry 1.49

P/Net Current Assets

1.03

Sector -11.70

Industry -11.70

P/Working Capital

0.89

Sector -3.19

Industry -3.19

EPS

-5.48

Sector -2.14

Industry -2.14

BVPS

12.62

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-742.67%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-754.00%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-43.42%

Sector -65.14%

Industry -65.14%

ROA

-33.22%

Sector -65.53%

Industry -65.53%

ROIC

-440.75%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.73

Sector 2.90

Industry 2.90

Net Debt / EBITDA

11.84

Sector -6.07

Industry -6.07

Net Debt / EBIT

11.67

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.23

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.76

Sector 0.41

Industry 0.41

Liabilities/Assets

0.24

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals RNA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RNA Avidity Biosciences Inc.	$13.71	-69.18%	0.00%	-2.32	1.01	-43.42%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Avidity Biosciences

Avidity Biosciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2020

Time since IPO - 6 years

120

Employees

Avidity Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $215.90 million, with shareholders equity totaling $214.58 million.

The company employs approximately 120 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Avidity Biosciences Inc. reported $35.84 million in revenue, generating net income of $-93.18 million.

Key financial metrics include a P/E ratio of -2.32, a price-to-book (P/B) ratio of 1.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RNA.

Market cap

$215.90 million

Net worth

$214.58 million

$214,580,000.00

Assets

$280.51 million

$280,510,000.00

Total Shares Outstanding

17.00 million

17,000,000

Average Daily Trading Volume

$182.96 Thousand

$182,962.50

Sector

Health Care

Industry

Biotechnology

RNA

RNA revenue and profits

Financial Results RNA

DRAG THE FRAME TO SEE MORE DATA

RNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Avidity Biosciences (RNA) today?

A cotação de Avidity Biosciences (RNA) hoje está em US$ 13.71, com uma variação de -68.86% em relação ao último ano. A cotação de Avidity Biosciences (RNA) iniciou o ano negociando na casa dos US$ 72.13 e hoje está em US$ 13.71. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Avidity Biosciences (RNA) e dados de ações do Ibovespa e mercados internacionais.

Quando Avidity Biosciences (RNA) paga dividendos?

Avidity Biosciences (RNA) não distribuiu dividendos no último ano.

Is Avidity Biosciences (RNA) a good investment?

Atualmente, Avidity Biosciences (RNA) está cotada a US$ 13.71, com um P/L de -2.32, representando um desvio de -2,099% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -68.86 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -68.86%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Avidity Biosciences (RNA) stock?

Investir em ações de Avidity Biosciences (RNA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Avidity Biosciences (RNA) yield today?

A rentabilidade de Avidity Biosciences (RNA) foi de 12.84% no último mês, -68.86% no último ano e -31.96% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Avidity Biosciences (RNA) hoje, o investimento total seria de US$ 1,371.00, com base na cotação atual de US$ 13.71.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 426.93
Em 5 anos: US$ 932.83
Em 10 anos: US$ 1,371.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RNA

Avidity Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RNA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RNA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Avidity Biosciences

Avidity Biosciences Inc.

United States

14 years

2020

120

Financial Results RNA

RNA cash flow

Asset, Revenue and Profit Growth - RNA

RNA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions